Single-cell transcriptomics has revolutionized the study of cellular diversity and function by enabling gene expression ...
As part of this consent agreement, Parse admitted that 10x's ATAC-seq patents are valid, enforceable and infringed by Parse's use of ATAC-seq methods and compositions. "This development further ...
10x Genomics (NASDAQ:TXG) announced on Monday that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences. On February 25, 2025, a consent agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results